Dewi Vernerey Selected Research

Dewi Vernerey Research Topics

Disease

16	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2015
13	Neoplasms (Cancer) 01/2022 - 03/2015
9	Colonic Neoplasms (Colon Cancer) 10/2021 - 12/2015
7	Adenocarcinoma 01/2022 - 10/2017
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2018
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 12/2019
4	Microsatellite Instability 01/2021 - 07/2016
3	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2019
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2020 - 12/2014
3	Rectal Neoplasms (Rectal Cancer) 05/2020 - 12/2005
3	Inflammation (Inflammations) 12/2014 - 08/2013
2	Carcinoma (Carcinomatosis) 01/2021 - 06/2020
2	Disease Progression 11/2020 - 11/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2019 - 04/2018
2	Pain (Aches) 06/2017 - 07/2016
2	Fibrosis (Cirrhosis) 01/2016 - 02/2015
2	Asthenia 11/2015 - 12/2014
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 11/2020
1	Margins of Excision 05/2020
1	Rare Diseases (Rare Disease) 04/2020
1	Stomach Neoplasms (Stomach Cancer) 04/2020
1	Turcot syndrome 04/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Kidney Neoplasms (Kidney Cancer) 04/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Breast Neoplasms (Breast Cancer) 06/2017
1	Cardiotoxicity 06/2017
1	Fatigue 06/2017
1	Atrophy 01/2016
1	Exanthema (Rash) 11/2015
1	Endarteritis 08/2015
1	Arteriosclerosis 08/2015

Drug/Important Bio-Agent (IBA)

12	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 12/2015
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 12/2014
7	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2014
5	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2018
4	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2020
4	Leucovorin (Folinic Acid)FDA Link 11/2020 - 12/2015
4	folfirinoxIBA 11/2020 - 12/2019
3	regorafenibIBA 01/2022 - 01/2021
3	Circulating Tumor DNAIBA 10/2021 - 07/2019
3	PlatinumIBA 01/2021 - 06/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 11/2020 - 12/2019
3	Tyrosine Kinase InhibitorsIBA 02/2019 - 11/2015
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 06/2017
2	Taxoids (Taxanes)IBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2015
2	IpilimumabIBA 11/2020 - 04/2020
2	NivolumabIBA 11/2020 - 04/2020
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2020 - 01/2019
2	Sunitinib (Sutent)FDA Link 02/2019 - 04/2018
2	Gemcitabine FDA Link 01/2019 - 12/2014
2	Complement System Proteins (Complement)IBA 08/2015 - 09/2013
2	AntibodiesIBA 08/2015 - 09/2013
1	trifluridine tipiracil drug combinationIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2022
1	Thymidylate SynthaseIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	tremelimumabIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	raltitrexed (D 1694)IBA 01/2021
1	durvalumabIBA 01/2021
1	avelumabIBA 06/2020
1	atezolizumabIBA 04/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	afliberceptIBA 01/2020
1	CarbohydratesIBA 12/2019
1	AntigensIBA 12/2019
1	pazopanib FDA Link 02/2019
1	Carcinoembryonic AntigenIBA 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2018
1	EpitopesIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 06/2017
1	Biological ProductsIBA 11/2016
1	Syndecan-1 (Syndecan 1)IBA 11/2016
1	AlbuminsIBA 07/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Dihydrotachysterol (AT 10)IBA 12/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015
1	Monoclonal AntibodiesIBA 11/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2015
1	Bevacizumab (Avastin)FDA Link 11/2015
1	Phenobarbital (Luminal)FDA Link 08/2015

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 01/2022 - 12/2014
8	Therapeutics 01/2022 - 11/2015
8	Adjuvant Chemotherapy 10/2021 - 12/2015
3	Duration of Therapy 10/2021 - 01/2018
3	Chemoradiotherapy 01/2021 - 05/2020
3	Radiotherapy 01/2021 - 06/2017
3	Immunotherapy 06/2020 - 11/2019
2	Induction Chemotherapy 01/2021 - 11/2020
2	Neoadjuvant Therapy 04/2020 - 11/2019
1	Pelvic Exenteration 10/2020
1	Combination Drug Therapy (Combination Chemotherapy) 06/2020